We’re working to remake medicine and challenge the status quo in drug development. We’re building a team of tenacious individuals who dream big, embrace innovation, and thrive on tackling big challenges to help people and society.


Sue Hager brings more than two decades of life sciences leadership expertise to EQRx. She served as Senior Vice President of Corporate Communications, Government Affairs and Patient Advocacy for Foundation Medicine. Sue was Senior Vice President, Corporate Communications and Government Affairs for Myriant Corporation and held leadership positions at Targanta Therapeutics, Coley Pharmaceutical Group, and Bayer Healthcare.

Sue is a member of the Board of Directors of MassBio. She holds an MBA and a B.S. degree in biology with honors from Northeastern University.

View All